Search research articles
Contact Us
Filters
Showing results (221-230 of 255) with videos related to
Page
of 26
Sort By:
Transplant Immunology
|
October 16, 2018
HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant
Duncan C Walton, Linda Cantwell, Steven Hiho, et al.
Plos One
|
July 5, 2013
Biosynthetic mechanism for sunscreens of the biocontrol agent Lysobacter enzymogenes
Yan Wang, Guoliang Qian, Yaoyao Li, et al.
Clinical Rheumatology
|
March 23, 2006
A study of male patients with forearm fracture in Northern Ireland
Stephen Wright, Timothy Beringer, Hugh Taggart, et al.
Parasitology
|
March 2, 2017
One hundred years of neglect in paediatric schistosomiasis
Amaya L Bustinduy, Stephen Wright, Elizabeth C Joekes, et al.
International Journal of Molecular Sciences
|
October 12, 2019
Role of Phytochemicals in Cancer Prevention
Alok Ranjan, Sharavan Ramachandran, Nehal Gupta, et al.
Journal of Pain and Symptom Management
|
September 20, 2017
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
Aron H Lichtman, Eberhard Albert Lux, Robert McQuade, et al.
Sexual Health
|
April 22, 2016
Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study
Nicole L De La Mata, David A Cooper, Darren Russell, et al.
British Journal of Pain
|
August 9, 2017
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies
Marie T Fallon, Eberhard Albert Lux, Robert McQuade, et al.
The New England Journal of Medicine
|
May 25, 2017
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky, J Helen Cross, Linda Laux, et al.
The Journal of Pain
|
April 10, 2012
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial
Russell K Portenoy, Elena Doina Ganae-Motan, Silvia Allende, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 255) with videos related to
Sort By:
Page
of 26
Transplant Immunology
|
October 16, 2018
HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant
Duncan C Walton, Linda Cantwell, Steven Hiho, et al.
Plos One
|
July 5, 2013
Biosynthetic mechanism for sunscreens of the biocontrol agent Lysobacter enzymogenes
Yan Wang, Guoliang Qian, Yaoyao Li, et al.
Clinical Rheumatology
|
March 23, 2006
A study of male patients with forearm fracture in Northern Ireland
Stephen Wright, Timothy Beringer, Hugh Taggart, et al.
Parasitology
|
March 2, 2017
One hundred years of neglect in paediatric schistosomiasis
Amaya L Bustinduy, Stephen Wright, Elizabeth C Joekes, et al.
International Journal of Molecular Sciences
|
October 12, 2019
Role of Phytochemicals in Cancer Prevention
Alok Ranjan, Sharavan Ramachandran, Nehal Gupta, et al.
Journal of Pain and Symptom Management
|
September 20, 2017
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
Aron H Lichtman, Eberhard Albert Lux, Robert McQuade, et al.
Sexual Health
|
April 22, 2016
Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study
Nicole L De La Mata, David A Cooper, Darren Russell, et al.
British Journal of Pain
|
August 9, 2017
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies
Marie T Fallon, Eberhard Albert Lux, Robert McQuade, et al.
The New England Journal of Medicine
|
May 25, 2017
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky, J Helen Cross, Linda Laux, et al.
The Journal of Pain
|
April 10, 2012
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial
Russell K Portenoy, Elena Doina Ganae-Motan, Silvia Allende, et al.
Page
of 26